HUP0203226A2 - Hatóanyagként benzamidszármazékot tartalmazó gyógyszerkészítmény - Google Patents

Hatóanyagként benzamidszármazékot tartalmazó gyógyszerkészítmény

Info

Publication number
HUP0203226A2
HUP0203226A2 HU0203226A HUP0203226A HUP0203226A2 HU P0203226 A2 HUP0203226 A2 HU P0203226A2 HU 0203226 A HU0203226 A HU 0203226A HU P0203226 A HUP0203226 A HU P0203226A HU P0203226 A2 HUP0203226 A2 HU P0203226A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
active ingredient
benzamide derivative
formula
benzamide
Prior art date
Application number
HU0203226A
Other languages
English (en)
Inventor
Tomoyuki Ando
Masahiko Ishibashi
Masahiro Sakabe
Ikuo Sakai
Tsuneji Suzuki
Original Assignee
Schering Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag. filed Critical Schering Ag.
Publication of HUP0203226A2 publication Critical patent/HUP0203226A2/hu
Publication of HUP0203226A3 publication Critical patent/HUP0203226A3/hu
Publication of HU230386B1 publication Critical patent/HU230386B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány szerinti gyógyszerkészítmény (1) általános képletűbenzamidszármazékot vagy ennek farmakológiailag alkalmazható sójáttartalmazza, a képletben A jelentése valamely (2) képletű csoport, egyvagy több gyógyszerészeti segédanyag, előnyösen hordozóanyag,szétesést elősegítő szer, kötőanyag, csúsztatószer, bevonószer és/vagyoldószer mellett. Ó
HU0203226A 1999-08-16 2000-08-16 Hatóanyagként benzamidszármazékot tartalmazó gyógyszerkészítmény HU230386B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22955199A JP2001064177A (ja) 1999-08-16 1999-08-16 ベンズアミド誘導体を有効成分とする製剤
JP11/229551 1999-08-16
PCT/EP2000/008011 WO2001012193A1 (en) 1999-08-16 2000-08-16 Pharmaceutical agent comprising a benzamide derivative as active ingredient

Publications (3)

Publication Number Publication Date
HUP0203226A2 true HUP0203226A2 (hu) 2003-01-28
HUP0203226A3 HUP0203226A3 (en) 2003-12-29
HU230386B1 HU230386B1 (hu) 2016-03-29

Family

ID=16893948

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203226A HU230386B1 (hu) 1999-08-16 2000-08-16 Hatóanyagként benzamidszármazékot tartalmazó gyógyszerkészítmény

Country Status (29)

Country Link
EP (1) EP1207881B1 (hu)
JP (2) JP2001064177A (hu)
KR (1) KR100683876B1 (hu)
CN (1) CN1205931C (hu)
AR (1) AR031074A1 (hu)
AU (1) AU780151B2 (hu)
BG (1) BG65662B1 (hu)
BR (1) BR0013283A (hu)
CA (1) CA2380757C (hu)
CY (1) CY1116273T1 (hu)
CZ (1) CZ302924B6 (hu)
DK (1) DK1207881T3 (hu)
EE (1) EE05331B1 (hu)
ES (1) ES2536705T3 (hu)
HK (1) HK1046501B (hu)
HR (1) HRP20020181B1 (hu)
HU (1) HU230386B1 (hu)
IL (1) IL148169A0 (hu)
MX (1) MXPA02001575A (hu)
NO (1) NO328957B1 (hu)
NZ (1) NZ517356A (hu)
PL (1) PL201388B1 (hu)
PT (1) PT1207881E (hu)
RU (1) RU2257206C2 (hu)
SK (1) SK287547B6 (hu)
TW (1) TWI245630B (hu)
UA (1) UA73316C2 (hu)
WO (1) WO2001012193A1 (hu)
ZA (1) ZA200201466B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001081031A (ja) * 1999-08-30 2001-03-27 Schering Ag 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
CA2423329A1 (en) * 2000-09-22 2003-03-20 Takeda Chemical Industries, Ltd. Solid preparations
WO2003075856A2 (en) 2002-03-07 2003-09-18 University Of Delaware Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
GB0316206D0 (en) 2003-07-10 2003-08-13 Glaxo Group Ltd Pharmaceutical formulation
KR20090125209A (ko) 2007-03-28 2009-12-03 산텐 세이야꾸 가부시키가이샤 히스톤 탈아세틸화 효소 저해 작용을 갖는 화합물을 유효 성분으로서 함유하는 안압 하강제
KR101405615B1 (ko) * 2007-08-27 2014-06-12 (주)아모레퍼시픽 조성물 내 ｐＨ 조절을 통해 안정화된 벤즈아미드 화합물을함유하는 피부 외용제 조성물, 및 그 벤즈아미드 화합물안정화 방법
PE20110677A1 (es) * 2008-08-29 2011-09-16 Bayer Ip Gmbh Polimorfo b de la n-(2-aminofenil)-4-[n-(piridin-3-il) metoxicarbonilamino-metil]benzamida (ms-275)
GB2462893B (en) * 2008-08-29 2010-10-13 Bayer Schering Pharma Ag N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
TWI645863B (zh) 2013-04-04 2019-01-01 日商第一三共股份有限公司 胺基羧酸之鹽的固形組成物
ES2766424T3 (es) 2015-03-19 2020-06-12 Daiichi Sankyo Co Ltd Preparación sólida que contienen agente oxidante
EP3272346A4 (en) 2015-03-19 2018-08-01 Daiichi Sankyo Company, Limited Solid preparation containing colorant
CA3096246C (en) 2018-07-30 2023-09-05 Daiichi Sankyo Company, Limited Stabilizer-containing solid drug formulation
WO2020153520A1 (ko) * 2019-01-25 2020-07-30 (주)아모레퍼시픽 벤조산아마이드 화합물 및 용해보조제를 포함하는 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3354090B2 (ja) * 1996-09-30 2002-12-09 シエーリング アクチエンゲゼルシャフト 分化誘導剤
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer

Also Published As

Publication number Publication date
AR031074A1 (es) 2003-09-10
EP1207881A1 (en) 2002-05-29
SK287547B6 (sk) 2011-01-04
UA73316C2 (uk) 2005-07-15
PT1207881E (pt) 2015-06-05
NO20020774L (no) 2002-03-04
KR20020020815A (ko) 2002-03-15
CA2380757C (en) 2009-01-27
BR0013283A (pt) 2002-04-23
RU2002106815A (ru) 2004-01-27
PL353449A1 (en) 2003-11-17
NO20020774D0 (no) 2002-02-15
TWI245630B (en) 2005-12-21
WO2001012193A1 (en) 2001-02-22
SK2092002A3 (en) 2002-07-02
HK1046501A1 (en) 2003-01-17
EE05331B1 (et) 2010-08-16
DK1207881T3 (da) 2015-06-22
AU6442700A (en) 2001-03-13
HK1046501B (zh) 2005-09-30
BG106516A (en) 2002-10-31
HU230386B1 (hu) 2016-03-29
CA2380757A1 (en) 2001-02-22
CZ302924B6 (cs) 2012-01-18
KR100683876B1 (ko) 2007-02-15
HRP20020181A2 (en) 2005-10-31
HUP0203226A3 (en) 2003-12-29
BG65662B1 (bg) 2009-05-29
NO328957B1 (no) 2010-06-28
CN1205931C (zh) 2005-06-15
JP2003507330A (ja) 2003-02-25
ES2536705T3 (es) 2015-05-27
EP1207881B1 (en) 2015-04-01
CZ2002540A3 (cs) 2002-06-12
IL148169A0 (en) 2002-09-12
NZ517356A (en) 2003-07-25
EE200200073A (et) 2003-04-15
CY1116273T1 (el) 2017-02-08
JP4854158B2 (ja) 2012-01-18
MXPA02001575A (es) 2003-10-14
HRP20020181B1 (hr) 2016-01-29
RU2257206C2 (ru) 2005-07-27
PL201388B1 (pl) 2009-04-30
AU780151B2 (en) 2005-03-03
CN1370068A (zh) 2002-09-18
ZA200201466B (en) 2002-09-02
JP2001064177A (ja) 2001-03-13

Similar Documents

Publication Publication Date Title
HUP0104573A2 (hu) Agrokémiai készítmények
MY119820A (en) Guanidine mimics as factor xa inhibitors
BR9910583A (pt) Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios
GEP20022709B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
BR9915727A (pt) ésteres derivados de compostos de fenil-ciclohexila substituìdos
EA200200571A1 (ru) Новая композиция и ее применение
RS50360B (sr) Farmaceutske formulacije derivata platine
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
ATE297203T1 (de) Antithrombotische mitteln
HRP20020182B1 (en) Benzamide formulation with histone deacetylase inhibitor activity
HUP0203028A2 (hu) Tolterodint tartalmazó gyógyszerkészítmény és alkalmazása
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
CA2343204A1 (en) Arylsulfonanilide ureas
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
HUP0203226A2 (hu) Hatóanyagként benzamidszármazékot tartalmazó gyógyszerkészítmény
RS51923B (en) SO 4 [[4 - [[4- (2-CYANOETHENYL) -2,6-DIMETHYLPHENYL] AMINO] -2-PYRIMIDINYL] AMINO] BENZONITRILA
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
SE0102440D0 (sv) New compound
DE69819539D1 (de) Antithrombotische mittel
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
DE69828522D1 (de) Antithrombotische mittel

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

Free format text: FORMER OWNER(S): SCHERING AG., DE

GB9A Succession in title

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

Free format text: FORMER OWNER(S): SCHERING AG., DE; BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE